Furthermore, Novo Nordisk is in the process of acquiring three manufacturing plants from Catalent, a leading contract development and manufacturing organization, to enhance its supply chain capabilities
This makes it easier for people to eat less and, as a result, lose weight over time
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): A double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
These reductions in body weight are comparable to the reductions seen in trials that proved Wegovy, another injectable form of Semaglutide, was effective for weight loss